Dublin, Sept. 02, 2021 (GLOBE NEWSWIRE) -- The "Blood Glucose Meters Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.
The global blood glucose meters market is expected to grow from $2.92 billion in 2020 to $3.99 billion in 2021 at a compound annual growth rate (CAGR) of 36.6%. The market is expected to reach $4.96 billion in 2025 at a CAGR of 5.6%.
Major players in the blood glucose meters market are Abbott, Roche, Medtronics, Ascensia and Dexcom.
FDA regulates the blood glucose meters. FDA has released its guidance for the accuracy of blood glucose meters. For blood glucose meters used in home by patients with diabetes, FDA states that 95% of the measured blood glucose levels should be within 15% of the lab tested value and 99% of the measured values should be within 20% of the lab tested value.
For point of care blood glucose monitoring devices, 95% of the monitored values must be within the range of 12% for blood sugars more than 75mg/dl and must be within 12mg/dl for blood sugars less than 75mg/dl. Also, 98% of the meter values must be within 15% of the range for blood sugars more than 75mg/dl and must be within 15mg/dl for blood sugars less than 75mg/dl.
Rising prevalence of diabetes is driving the blood glucose meters market. The changing lifestyle, increase in alcohol consumption, physical inactivity and unhealthy eating habits are leading to an increase in obesity across the globe. Such exponential growth in obese people is causing a stern increase in the purchase of blood glucose meters.
Due to obesity, fat tissues release more fat molecules into the blood affecting insulin responsive cells, which results in reduced insulin sensitivity, in turn, causing diabetes. According to the study by the International Diabetes Federation (IDF), there will be a 48% increase in diabetes around the world by 2045. According to the International Diabetes Federation (IDF) in 2019, nearly 4.2 million deaths were caused by diabetes.
The blood glucose meters market growth is restricted due to lack of awareness of diabetes. Hypo unawareness is a common term used to describe the people who have diabetes, especially type 1 diabetes, it is very difficult to notice when they have low blood glucose, hypoglycemia. Such lack of awareness of diabetes and its effects reduces the regular monitoring or check-ups relating to diabetes.
Key Topics Covered:
1. Executive Summary
2. Blood Glucose Meters Market Characteristics
3. Blood Glucose Meters Market Trends And Strategies
4. Impact Of COVID-19 on Blood Glucose Meters
5. Blood Glucose Meters Market Size And Growth
5.1. Global Blood Glucose Meters Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on The Market
5.2. Global Blood Glucose Meters Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market
6. Blood Glucose Meters Market Segmentation
6.1. Global Blood Glucose Meters Market, Segmentation By Product type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
- Electrode Type Blood Glucose Meter
- Photoelectric Blood Glucose Meter
6.2. Global Blood Glucose Meters Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
- Hospitals
- Home Care
6.3. Global Blood Glucose Meters Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
7. Blood Glucose Meters Market Regional And Country Analysis
7.1. Global Blood Glucose Meters Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Blood Glucose Meters Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
Companies Mentioned
- Abbott
- Roche
- Medtronics
- Ascensia
- Dexcom
- Johnson & Johnson
- Arkray
- Acon
- LifeScan
- Agamatrix Inc
- Trivida
- Medisana
- Bayer AG
- B Braun Medical
- 77 Elektronika Kft
- Bionime Corp
- Rossmax
- Omron Healthcare
- Grace Medical
- I Sens
- Infopia
- Hainice Medical
- Mendor
- All Medicus
- Delta
- Terumo Corp
- Becton & Dickinson and Co
- Tandem Diabetes Care
For more information about this report visit https://www.researchandmarkets.com/r/5csvg8
